A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma

Genome Medicine

Volumn 6, Issue 10, 2014, Pages

  Galasso, Marco ^a   Dama, Paola ^a   Previati, Maurizio ^a   Sandhu, Sukhinder ^b   Palatini, Jeff ^b   Coppola, Vincenzo ^b   Warner, Sarah ^b   Sana, Maria E ^a   Zanella, Riccardo ^a   Abujarour, Ramzey ^e   Desponts, Caroline ^f   Teitell, Michael A ^g   Garzon, Ramiro ^b   Calin, George ^d   Croce, Carlo M ^b   Volinia, Stefano ^a,b,c  

^a UNIVERSITY OF FERRARA   (Italy)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e Fate Therapeutics   (United States)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA;

ANIMAL CELL; ARTICLE; CANCER STEM CELL; CANCER TISSUE; CONTROLLED STUDY; DNA SEQUENCE; EMBRYONIC STEM CELL; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; RNA SEQUENCE; RNA STRUCTURE; ULTRA CONSERVED REGION;

EID: 84927950549     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-014-0076-4     Document Type: Article

References (42)

1. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009, 10:155-159. 10.1038/nrg2521, 19188922.
2. Bejerano G, Pheasant M, Makunin I, Stephen S, Kent WJ, Mattick JS, Haussler D. Ultraconserved elements in the human genome. Science 2004, 304:1321-1325. 10.1126/science.1098119, 15131266.
3. Bejerano G, Lowe CB, Ahituv N, King B, Siepel A, Salama SR, Rubin EM, Kent WJ, Haussler D. A distal enhancer and an ultraconserved exon are derived from a novel retroposon. Nature 2006, 441:87-90. 10.1038/nature04696, 16625209.
4. Poulin F, Nobrega MA, Plajzer-Frick I, Holt A, Afzal V, Rubin EM, Pennacchio LA. In vivo characterization of a vertebrate ultraconserved enhancer. Genomics 2005, 85:774-781. 10.1016/j.ygeno.2005.03.003, 15885503.
5. Pennacchio LA, Ahituv N, Moses AM, Prabhakar S, Nobrega MA, Shoukry M, Minovitsky S, Dubchak I, Holt A, Lewis KD, Plajzer-Frick I, Akiyama J, De Val S, Afzal V, Black BL, Couronne O, Eisen MB, Visel A, Rubin EM. In vivo enhancer analysis of human conserved non-coding sequences. Nature 2006, 444:499-502. 10.1038/nature05295, 17086198.
6. Baira E, Greshock J, Coukos G, Zhang L. Ultraconserved elements: genomics, function and disease. RNA Biol 2008, 5:132-134. 10.4161/rna.5.3.6673, 18708752.
7. Katzman S, Kern AD, Bejerano G, Fewell G, Fulton L, Wilson RK, Salama SR, Haussler D. Human genome ultraconserved elements are ultraselected. Science 2007, 317:915. 10.1126/science.1142430, 17702936.
8. Licastro D, Gennarino VA, Petrera F, Sanges R, Banfi S, Stupka E. Promiscuity of enhancer, coding and non-coding transcription functions in ultraconserved elements. BMC Genomics 2010, 11:151. 10.1186/1471-2164-11-151, 20202189.
9. Nielsen MM, Tehler D, Vang S, Sudzina F, Hedegaard J, Nordentoft I, Orntoft TF, Lund AH, Pedersen JS. Identification of expressed and conserved human noncoding RNAs. RNA 2014, 20:236-251. 10.1261/rna.038927.113, 24344320.
10. Liz J, Portela A, Soler M, Gomez A, Ling H, Michlewski G, Calin GA, Guil S, Esteller M. Regulation of pri-miRNA processing by a long noncoding RNA transcribed from an ultraconserved region. Mol Cell 2014, 55:3-4. 10.1016/j.molcel.2014.05.005.
11. Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-Manero G, Calin GA. MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia 2008, 22:1095-1105. 10.1038/leu.2008.30, 18323801.
12. Galasso M, Elena Sana M, Volinia S. Non-coding RNAs: a key to future personalized molecular therapy?. Genome Med 2010, 2:12. 10.1186/gm133, 20236487.
13. Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, Shimizu M, Tili E, Rossi S, Taccioli C, Pichiorri F, Liu X, Zupo S, Herlea V, Gramantieri L, Lanza G, Alder H, Rassenti L, Volinia S, Schmittgen TD, Kipps TJ, Negrini M, Croce CM. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 2007, 12:215-229. 10.1016/j.ccr.2007.07.027, 17785203.
14. Rossi S, Sevignani C, Nnadi SC, Siracusa LD, Calin GA. Cancer-associated genomic regions (CAGRs) and noncoding RNAs: bioinformatics and therapeutic implications. Mamm Genome 2008, 19:526-540. 10.1007/s00335-008-9119-8, 18636290.
15. Scaruffi P, Stigliani S, Moretti S, Coco S, De Vecchi C, Valdora F, Garaventa A, Bonassi S, Tonini GP. Transcribed-ultra conserved region expression is associated with outcome in high-risk neuroblastoma. BMC Cancer 2009, 9:441. 10.1186/1471-2407-9-441, 20003513.
16. Mestdagh P, Fredlund E, Pattyn F, Rihani A, Van Maerken T, Vermeulen J, Kumps C, Menten B, De Preter K, Schramm A, Schulte J, Noguera R, Schleiermacher G, Janoueix-Lerosey I, Laureys G, Powel R, Nittner D, Marine JC, Ringnér M, Speleman F, Vandesompele J. An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours. Oncogene 2010, 29:3583-3592. 10.1038/onc.2010.106, 20383195.
17. Yang R, Frank B, Hemminki K, Bartram CR, Wappenschmidt B, Sutter C, Kiechle M, Bugert P, Schmutzler RK, Arnold N, Weber BH, Niederacher D, Meindl A, Burwinkel B. SNPs in ultraconserved elements and familial breast cancer risk. Carcinogenesis 2008, 29:351-355. 10.1093/carcin/bgm290, 18174240.
18. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006, 103:2257-2261. 10.1073/pnas.0510565103, 16461460.
19. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193. 10.1093/bioinformatics/19.2.185, 12538238.
20. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Foà R, Schliwka J, Fuchs U, Novosel A, Müller RU, Schermer B, Bissels U, Inman J, Phan Q, Chien M, Weir DB, Choksi R, De Vita G, Frezzetti D, Trompeter HI, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414. 10.1016/j.cell.2007.04.040, 17604727.
21. Simon R, Lam A, Li MC, Ngan M, Menenzes S, Zhao Y. Analysis of gene expression data using BRB-ArrayTools. Cancer Inform 2007, 3:11-17. [http://linus.nci.nih.gov/BRB-ArrayTools.html], 19455231.
22. Busch A, Richter AS, Backofen R. IntaRNA: efficient prediction of bacterial sRNA targets incorporating target site accessibility and seed regions. Bioinformatics 2008, 24:2849-2856. 10.1093/bioinformatics/btn544, 18940824.
23. Richter AS, Schleberger C, Backofen R, Steglich C. Seed-based INTARNA prediction combined with GFP-reporter system identifies mRNA targets of the small RNA Yfr1. Bioinformatics 2010, 26:1-5. 10.1093/bioinformatics/btp609, 19850757.
24. Gruber AR, Lorenz R, Bernhart SH, Neubock R, Hofacker IL. The Vienna RNA websuite. Nucleic Acids Res 2008, 36:W70-W74. 10.1093/nar/gkn188, 18424795.
25. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, Bottoni A, Gasparini P, Harris CC, Visone R, Pekarsky Y, et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Res 2010, 20:589-599. 10.1101/gr.098046.109, 20439436.
26. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005, 353:1793-1801. 10.1056/NEJMoa050995, 16251535.
27. Visel A, Minovitsky S, Dubchak I, Pennacchio LA. VISTA Enhancer Browser-a database of tissue-specific human enhancers. Nucleic Acids Res 2007, 35:D88-D92. 10.1093/nar/gkl822, 17130149.
28. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M, Ku M, Durham T, Kellis M, Bernstein BE. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011, 473:43-49. 10.1038/nature09906, 21441907.
29. Sigova AA, Mullen AC, Molinie B, Gupta S, Orlando DA, Guenther MG, Almada AE, Lin C, Sharp PA, Giallourakis CC, Young RA. Divergent transcription of long noncoding RNA/mRNA gene pairs in embryonic stem cells. Proc Natl Acad Sci U S A 2013, 110:2876-2881. 10.1073/pnas.1221904110, 23382218.
30. Magee JA, Piskounova E, Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 2012, 21:283-296. 10.1016/j.ccr.2012.03.003, 22439924.
31. Watkins S, Sontheimer H. Unique biology of gliomas: challenges and opportunities. Trends Neurosci 2012, 35:546-556. 10.1016/j.tins.2012.05.001, 22683220.
32. Zhang X, Sun S, Pu JK, Tsang AC, Lee D, Man VO, Lui WM, Wong ST, Leung GK. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis 2012, 48:1-8. 10.1016/j.nbd.2012.06.004, 22709987.
33. Gronych J, Pfister SM, Jones DT. Connect four with glioblastoma stem cell factors. Cell 2014, 157:525-527. 10.1016/j.cell.2014.04.001, 24766799.
34. Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene 2010, 29:6390-6401. 10.1038/onc.2010.361, 20802525.
35. Hudson RS, Yi M, Volfovsky N, Prueitt RL, Esposito D, Volinia S, Liu CG, Schetter AJ, Van Roosbroeck K, Stephens RM, Calin GA, Croce CM, Ambs S. Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Mol Cancer 2013, 12:13. 10.1186/1476-4598-12-13, 23409773.
36. Lorenz R, Bernhart SH, Honer Zu Siederdissen C, Tafer H, Flamm C, Stadler PF, Hofacker IL. ViennaRNA Package 2.0. Algorithms for molecular biology. AMB 2011, 6:26. 22115189.
37. Muckstein U, Tafer H, Hackermuller J, Bernhart SH, Stadler PF, Hofacker IL. Thermodynamics of RNA-RNA binding. Bioinformatics 2006, 22:1177-1182. 10.1093/bioinformatics/btl024, 16446276.
38. Chang TH, Huang HY, Hsu JB, Weng SL, Horng JT, Huang HD. An enhanced computational platform for investigating the roles of regulatory RNA and for identifying functional RNA motifs. BMC Bioinformatics 2013, 14:S4.
39. Bar M, Wyman SK, Fritz BR, Qi J, Garg KS, Parkin RK, Kroh EM, Bendoraite A, Mitchell PS, Nelson AM, Ruzzo WL, Ware C, Radich JP, Gentleman R, Ruohola-Baker H, Tewari M. MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries. Stem Cells 2008, 26:2496-2505. 10.1634/stemcells.2008-0356, 18583537.
40. Li Y, Mine T, Ioannides CG. Short GC-rich RNA similar to miR 1909 and 1915 folds in silico with the 5?-UTR and ORF of Notch and responders: potential for the elimination of cancer stem cells. Oncol Rep 2010, 24:1443-1453. 21042738.
41. Saito K, Inagaki K, Kamimoto T, Ito Y, Sugita T, Nakajo S, Hirasawa A, Iwamaru A, Ishikura T, Hanaoka H, Okubo K, Onozaki T, Zama T. MicroRNA-196a is a putative diagnostic biomarker and therapeutic target for laryngeal cancer. PloS One 2013, 8:e71480. 10.1371/journal.pone.0071480, 23967217.
42. Li X, Lu Y, Chen Y, Lu W, Xie X. MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples. BMC Cancer 2013, 13:216. 10.1186/1471-2407-13-216, 23627607.